Dynamic magnetic resonance imaging of tumor perfusion. Approaches and biomedical challenges.
暂无分享,去创建一个
[1] G Brix,et al. Pathophysiologic basis of contrast enhancement in breast tumors , 1999, Journal of magnetic resonance imaging : JMRI.
[2] J. Witjes,et al. Evaluation of chemotherapy in advanced urinary bladder cancer with fast dynamic contrast-enhanced MR imaging. , 1998, Radiology.
[3] L. Blumenson,et al. Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions , 1997, Breast Cancer Research and Treatment.
[4] Gerhard Laub,et al. Contrast‐enhanced breath‐hold three‐dimensional magnetic resonance angiography in the evaluation of renal arteries: Optimization of technique and pitfalls , 2000, Journal of magnetic resonance imaging : JMRI.
[5] C Zimmer,et al. Pharmacokinetic analysis of glioma compartments with dynamic Gd-DTPA-enhanced magnetic resonance imaging. , 2000, Magnetic resonance imaging.
[6] O. Haraldseth,et al. Differentiating Benign and Malignant Breast Lesions with T2*-Weighted First Pass Perfusion Imaging , 1999, Acta radiologica.
[7] A. Jackson,et al. Reproducibility of T2* blood volume and vascular tortuosity maps in cerebral gliomas , 2001, Journal of magnetic resonance imaging : JMRI.
[8] Y. N. Park,et al. Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis. , 2000, Archives of pathology & laboratory medicine.
[9] R. Brasch,et al. MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: status report. , 2000, European journal of radiology.
[10] David J. Hawkes,et al. Validation of Volume-Preserving Non-rigid Registration: Application to Contrast-Enhanced MR-Mammography , 2002, MICCAI.
[11] G J Parker,et al. Pharmacokinetic analysis of neoplasms using contrast-enhanced dynamic magnetic resonance imaging. , 1999, Topics in magnetic resonance imaging : TMRI.
[12] W E Reddick,et al. Dynamic MR imaging (DEMRI) of microcirculation in bone sarcoma , 1999, Journal of magnetic resonance imaging : JMRI.
[13] J. A. den Boer,et al. Pharmacokinetic Analysis of Gd‐DTPA Enhancement in dynamic three‐dimensional MRI of breast lesions , 1997, Journal of magnetic resonance imaging : JMRI.
[14] W. Hacke,et al. MRI in acute cerebral ischaemia: perfusion imaging with superparamagnetic iron oxide in a rat model , 2004, Neuroradiology.
[15] J. Folkman. New perspectives in clinical oncology from angiogenesis research. , 1996, European journal of cancer.
[16] B Asselain,et al. Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging. , 1993, Radiology.
[17] P. Tofts. Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.
[18] K. Zierler. Theory of Use of Indicators to Measure Blood Flow and Extracellular Volume and Calculation of Transcapillary Movement of Tracers , 1963 .
[19] D M Shames,et al. Quantification of the extraction fraction for gadopentetate across breast cancer capillaries , 1998, Magnetic resonance in medicine.
[20] J. Waterton,et al. Use of dynamic contrast-enhanced MRI to evaluate acute treatment with ZD6474, a VEGF signalling inhibitor, in PC-3 prostate tumours , 2003, British Journal of Cancer.
[21] P S Tofts,et al. Measurement of blood‐brain barrier permeability using dynamic Gd‐DTPA scanning—a comparison of methods , 1992, Magnetic resonance in medicine.
[22] S. Kety. The theory and applications of the exchange of inert gas at the lungs and tissues. , 1951, Pharmacological reviews.
[23] A. Kaider,et al. Vascular endothelial growth factor (VEGF) in human breast cancer: Correlation with disease‐free survival , 1997, International journal of cancer.
[24] P S Tofts,et al. Quantitative Analysis of Dynamic Gd‐DTPA Enhancement in Breast Tumors Using a Permeability Model , 1995, Magnetic resonance in medicine.
[25] C. Kuhl,et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? , 1999, Radiology.
[26] W. Kaiser,et al. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. , 1989, Radiology.
[27] A. Padhani,et al. Non‐invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer , 2001, The British journal of surgery.
[28] M O Leach,et al. Improving image quality and T(1) measurements using saturation recovery turboFLASH with an approximate K-space normalisation filter. , 2000, Magnetic resonance imaging.
[29] E F Halpern,et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. , 1994, Radiology.
[30] B. Rosen,et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results , 1996, Magnetic resonance in medicine.
[31] J. Renou,et al. Measurements of extracellular volume fraction and capillary permeability in tissues using dynamic spin-lattice relaxometry: studies in rabbit muscles. , 2003, Magnetic resonance imaging.
[32] A. Padhani,et al. Effects of 5,6-dimethylxanthenone-4-acetic acid on human tumor microcirculation assessed by dynamic contrast-enhanced magnetic resonance imaging. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] W P Dillon,et al. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. , 2000, AJNR. American journal of neuroradiology.
[34] K. Kinkel,et al. Dynamic contrast-enhanced subtraction versus T2-weighted spin-echo MR imaging in the follow-up of colorectal neoplasm: a prospective study of 41 patients. , 1996, Radiology.
[35] S. Ascher,et al. Symptomatic fibroleiomyomata: MR imaging of the uterus before and after uterine arterial embolization. , 2000, Radiology.
[36] M Takahashi,et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. , 1998, AJR. American journal of roentgenology.
[37] Gabriel P. Krestin,et al. Contrast‐Enhanced Endorectal Coil MRI in Local Staging of Prostate Carcinoma , 1995, Journal of computer assisted tomography.
[38] M. Décorps,et al. Methodology of brain perfusion imaging , 2001, Journal of magnetic resonance imaging : JMRI.
[39] A. Horsman,et al. Dynamic contrast-enhanced and fat suppressed magnetic resonance imaging in suspected recurrent carcinoma of the breast: preliminary experience. , 1994, The British journal of radiology.
[40] P J Drew,et al. Microvessel density in invasive breast cancer assessed by dynamic gd‐dtpa enhanced MRI , 1997 .
[41] G. Johnson,et al. Dynamic susceptibility contrast MR imaging: Correlation of signal intensity changes with cerebral blood volume measurements , 2000, Journal of magnetic resonance imaging : JMRI.
[42] L. Østergaard,et al. Comparison of gradient‐ and spin‐echo imaging: CBF, CBV, and MTT measurements by bolus tracking , 2000, Journal of magnetic resonance imaging : JMRI.
[43] P. Tofts,et al. Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.
[44] B R Rosen,et al. NMR imaging of changes in vascular morphology due to tumor angiogenesis , 1998, Magnetic resonance in medicine.
[45] S F Keevil,et al. Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. UK MRI Breast Screening Study Advisory Group. , 2000, Magnetic resonance imaging.
[46] T Hackländer,et al. Comparison of cerebral blood volume measurements using the T1 and T2* methods in normal human brains and brain tumors. , 1997, Journal of computer assisted tomography.
[47] L. Bonomo,et al. Magnetic resonance of the breast: correlation between enhancement patterns and microvessel density in malignant tumors. , 2002, Journal of experimental & clinical cancer research : CR.
[48] K. Verstraete,et al. Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery. , 1995, AJR. American journal of roentgenology.
[49] D B Kopans,et al. Dynamic echo-planar imaging of the breast: experience in diagnosing breast carcinoma and correlation with tumor angiogenesis. , 1997, Radiology.
[50] M E Moseley,et al. Comparison of Gd‐ and Dy‐chelates for T2* Contrast‐Enhanced Imaging , 1991, Magnetic resonance in medicine.
[51] Orhan Nalcioglu,et al. Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer , 2003, Journal of magnetic resonance imaging : JMRI.
[52] J R Griffiths,et al. Issues in flow and oxygenation dependent contrast (FLOOD) imaging of tumours , 2001, NMR in biomedicine.
[53] A. Simmons,et al. Effects of three different doses of a bolus injection of gadodiamide: assessment of regional cerebral blood volume maps in a blinded reader study. , 2000, AJNR. American journal of neuroradiology.
[54] T. Roberts,et al. Physiologic measurements by contrast‐enhanced MR imaging: Expectations and limitations , 1997, Journal of magnetic resonance imaging : JMRI.
[55] J L Bloem,et al. Musculoskeletal tumors: does fast dynamic contrast-enhanced subtraction MR imaging contribute to the characterization? , 1998, Radiology.
[56] R. Kerbel,et al. Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. , 1995, Anti-cancer drugs.
[57] R. Matsubayashi,et al. Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors. , 2000, Radiology.
[58] G Johnson,et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. , 1999, Radiology.
[59] H. Schlemmer,et al. Can preoperative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens? , 2004 .
[60] M. Dewhirst,et al. Fourier analysis of fluctuations of oxygen tension and blood flow in R3230Ac tumors and muscle in rats. , 1999, American journal of physiology. Heart and circulatory physiology.
[61] P. Vermeulen,et al. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy. , 1999, The cancer journal from Scientific American.
[62] M Takahashi,et al. Value of dynamic susceptibility contrast magnetic resonance imaging in the evaluation of intracranial tumors. , 1999, Topics in magnetic resonance imaging : TMRI.
[63] A. Padhani,et al. Reproducibility of quantitative dynamic MRI of normal human tissues , 2002, NMR in biomedicine.
[64] S. Williams,et al. Assessment of anti-angiogenic and anti-vascular therapeutics using Magnetic Resonance Imaging: recommendations for appropriate methodology for clinical trials. , 2003 .
[65] S. Fox,et al. Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. , 1996, European journal of cancer.
[66] D Artemov,et al. Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts. , 2001, Neoplasia.
[67] J Sau,et al. A model of the dual effect of gadopentetate dimeglumine on dynamic brain MR images , 1999, Journal of magnetic resonance imaging : JMRI.
[68] Fabian Kiessling,et al. Comparing Dynamic Parameters of Tumor Vascularization in Nude Mice Revealed by Magnetic Resonance Imaging and Contrast‐Enhanced Intermittent Power Doppler Sonography , 2003, Investigative radiology.
[69] R. Gillies,et al. Applications of magnetic resonance in model systems: tumor biology and physiology. , 2000, Neoplasia.
[70] A R Padhani,et al. In vivo monitoring of tumor angiogenesis with MR imaging. , 2000, Academic radiology.
[71] A. Padhani. Dynamic contrast‐enhanced MRI in clinical oncology: Current status and future directions , 2002, Journal of magnetic resonance imaging : JMRI.
[72] A R Padhani,et al. Probing tumor microvascularity by measurement, analysis and display of contrast agent uptake kinetics , 1997, Journal of magnetic resonance imaging : JMRI.
[73] R. Herbst,et al. Angiogenesis as a target for cancer therapy. , 2002, Hematology/oncology clinics of North America.
[74] First-pass myocardial perfusion MR imaging with outer-volume suppression and the intravascular contrast agent NC100150 injection: preliminary results in eight patients. , 2001, Radiology.
[75] N. Weidner,et al. Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow , 1998, The Journal of pathology.
[76] M. Knopp,et al. Effect of radiation on blood volume in low-grade astrocytomas and normal brain tissue: quantification with dynamic susceptibility contrast MR imaging. , 1996, AJR. American journal of roentgenology.
[77] A. Padhani,et al. Reproducibility of dynamic contrast‐enhanced MRI in human muscle and tumours: comparison of quantitative and semi‐quantitative analysis , 2002, NMR in biomedicine.
[78] P. Gowland,et al. Dynamic studies of gadolinium uptake in brain tumors using inversion‐recovery echo‐planar imaging , 1992, Magnetic resonance in medicine.
[79] O Nalcioglu,et al. Measurement of vascular volume fraction and blood‐tissue permeability constants with a pharmacokinetic model: Studies in rat muscle tumors with dynamic Gd‐DTPA enhanced MRI , 1994, Magnetic resonance in medicine.
[80] B. Vojnovic,et al. Evaluation of the anti‐vascular effects of combretastatin in rodent tumours by dynamic contrast enhanced MRI , 2002, NMR in biomedicine.
[81] W P Dillon,et al. Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumors. , 2001, Academic radiology.
[82] H Okamura,et al. Dynamic contrast-enhanced MR imaging of uterine cervical cancer: pharmacokinetic analysis with histopathologic correlation and its importance in predicting the outcome of radiation therapy. , 2000, Radiology.
[83] R Weissleder,et al. Molecular imaging. , 2009, Radiology.
[84] J. Gomori,et al. Utility of relative cerebral blood volume mapping derived from perfusion magnetic resonance imaging in the routine follow up of brain tumors. , 1997, Journal of neurosurgery.
[85] B. Rosen,et al. Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors. , 1999, Journal of neurosurgery.
[86] A Heerschap,et al. Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors , 2001, Journal of magnetic resonance imaging : JMRI.
[87] O Salonen,et al. MRI enhancement and microvascular density in gliomas. Correlation with tumor cell proliferation. , 1999, Investigative radiology.
[88] J L Evelhoch,et al. Key factors in the acquisition of contrast kinetic data for oncology , 1999, Journal of magnetic resonance imaging : JMRI.
[89] R. Gilles,et al. Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: preliminary results in 26 patients. , 1993, Radiology.
[90] W. J. Lorenz,et al. Pharmacokinetic Mapping of the Breast: A New Method for Dynamic MR Mammography , 1995, Magnetic resonance in medicine.
[91] R. Henriksson,et al. Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[92] M. Knopp,et al. Functional tumor imaging with dynamic contrast‐enhanced magnetic resonance imaging , 2003, Journal of magnetic resonance imaging : JMRI.
[93] L R Schad,et al. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. , 1991, Journal of computer assisted tomography.
[94] D P Dearnaley,et al. Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging. , 2001, Radiology.
[95] G Brix,et al. Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma. , 2001, Cancer research.
[96] A Horsman,et al. Dynamic Contrast-Enhanced Magnetic Resonance Imaging of the Breast Combined with Pharmacokinetic Analysis of Gadolinium-DTPA Uptake in the Diagnosis of Local Recurrence of Early Stage Breast Carcinoma , 1995, Investigative radiology.
[97] G Brix,et al. MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. , 1994, Magnetic resonance imaging clinics of North America.
[98] R I Grossman,et al. Gliomas: correlation of magnetic susceptibility artifact with histologic grade. , 1997, Radiology.
[99] I. Gribbestad,et al. Comparative signal intensity measurements in dynamic gadolinium‐enhanced MR mammography , 1994, Journal of magnetic resonance imaging : JMRI.
[100] P S Tofts,et al. Measurement of capillary permeability from the Gd enhancement curve: a comparison of bolus and constant infusion injection methods. , 1994, Magnetic resonance imaging.
[101] W Zhen,et al. Pixel analysis of MR perfusion imaging in predicting radiation therapy outcome in cervical cancer , 2000, Journal of magnetic resonance imaging : JMRI.
[102] B. Rosen,et al. Contrast agents in functional MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.
[103] O Henriksen,et al. Quantitation of blood‐brain barrier defect by magnetic resonance imaging and gadolinium‐DTPA in patients with multiple sclerosis and brain tumors , 1990, Magnetic resonance in medicine.
[104] J. Evelhoch. Consensus Recommendations for Acquisition of Dynamic Contrasted-Enhanced MRI Data in Oncology , 2005 .
[105] Robert C Brasch,et al. Dynamic contrast‐enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti‐angiogenic therapy in a xenograft model of glioblastoma multiforme , 2002, Journal of magnetic resonance imaging : JMRI.
[106] C Kremser,et al. Monitoring of tumor microcirculation during fractionated radiation therapy in patients with rectal carcinoma: preliminary results and implications for therapy. , 2000, Radiology.
[107] J P Logue,et al. Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[108] A. Padhani,et al. Assessing changes in tumour vascular function using dynamic contrast‐enhanced magnetic resonance imaging , 2002, NMR in biomedicine.
[109] H. Dvorak,et al. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. , 1999, Current topics in microbiology and immunology.
[110] M. Knopp,et al. Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.
[111] J. Folkman. Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.
[112] M V Knopp,et al. Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.
[113] C. Hutchinson,et al. Quantitative dynamic contrast enhanced MRI of recurrent pelvic masses in patients treated for cancer. , 1998, The British journal of radiology.
[114] Characterization of hepatic lesions by perfusion-weighted MR imaging with an echoplanar sequence. , 1998, AJR. American journal of roentgenology.
[115] H Lyng,et al. Assessment of tumor oxygenation in human cervical carcinoma by use of dynamic Gd‐DTPA‐enhanced MR imaging , 2001, Journal of magnetic resonance imaging : JMRI.
[116] K Scheffler,et al. Analysis of input functions from different arterial branches with gamma variate functions and cluster analysis for quantitative blood volume measurements. , 2000, Magnetic resonance imaging.
[117] Scott Fields,et al. Mapping pathophysiological features of breast tumors by MRI at high spatial resolution , 1997, Nature Medicine.
[118] D. Pode,et al. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. , 1999, The Journal of clinical investigation.
[119] A. Bjørnerud,et al. Renal T *2 perfusion using an iron oxide nanoparticle contrast agent—influence of T1 relaxation on the first‐pass response , 2002, Magnetic resonance in medicine.
[120] D. Cosgrove,et al. Quantification of blood flow , 2001, European Radiology.
[121] G. Glover,et al. Breast disease: dynamic spiral MR imaging. , 1998, Radiology.
[122] Martin A Lodge,et al. Combretastatin A4 phosphate has tumor antivascular activity in rat and man as demonstrated by dynamic magnetic resonance imaging. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[123] Robert C. Brasch,et al. MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[125] N. van Bruggen,et al. Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor. , 1998, Cancer investigation.
[126] C K Kuhl,et al. Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging. , 1997, Radiology.
[127] M. Dewhirst,et al. Magnetic resonance imaging applications in the evaluation of tumor angiogenesis. , 2001, Seminars in radiation oncology.
[128] L J van Erning,et al. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. , 1994, Radiology.
[129] Mark S. Cohen,et al. Contrast agents and cerebral hemodynamics , 1991, Magnetic resonance in medicine.
[130] C. Crone,et al. THE PERMEABILITY OF CAPILLARIES IN VARIOUS ORGANS AS DETERMINED BY USE OF THE 'INDICATOR DIFFUSION' METHOD. , 1963, Acta physiologica Scandinavica.
[131] Evaluation of area under curve (Gd) data derived from DCE-MRI time series in brain tumours , 2003 .
[132] M. Knopp,et al. Age dependency of the regional cerebral blood volume (rCBV) measured with dynamic susceptibility contrast MR imaging (DSC). , 1996, Magnetic resonance imaging.
[133] David L Buckley,et al. Transcytolemmal water exchange and its affect on the determination of contrast agent concentration in vivo , 2002, Magnetic resonance in medicine.
[134] B. Rosen,et al. Contrast‐to‐noise ratio in functional MRI of relative cerebral blood volume with sprodiamide injection , 1997, Journal of magnetic resonance imaging : JMRI.
[135] P. Carmeliet,et al. Molecular mechanisms of blood vessel growth. , 2001, Cardiovascular research.
[136] S. Heywang-Köbrunner,et al. Contrast‐Enhanced MRI of the Breast after Limited Surgery and Radiation Therapy , 1993, Journal of computer assisted tomography.
[137] J. Allison,et al. Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MRI. , 1993, Magnetic resonance imaging.
[138] G Brix,et al. Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. , 1997, Cancer research.
[139] B. Rosen,et al. Echo-planar MR cerebral blood volume mapping of gliomas. Clinical utility. , 1996, Acta radiologica.
[140] J R Thornbury,et al. Dynamic TurboFLASH subtraction technique for contrast-enhanced MR imaging of the prostate: correlation with histopathologic results. , 1997, Radiology.
[141] J. Healy,et al. Uterine fibroleiomyoma: MR imaging appearances before and after embolization of uterine arteries. , 2000, Radiology.
[142] J A d'Arcy,et al. Applications of sliding window reconstruction with cartesian sampling for dynamic contrast enhanced MRI , 2002, NMR in biomedicine.
[143] Glyn Johnson,et al. Dynamic, contrast‐enhanced perfusion MRI in mouse gliomas: Correlation with histopathology , 2003, Magnetic resonance in medicine.
[144] P. Peters,et al. Application of a superparamagnetic iron oxide (Resovis®) for MR imaging of human cerebral blood volume , 1995, Magnetic resonance in medicine.
[145] H. Weinmann,et al. Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers. , 1984, Physiological chemistry and physics and medical NMR.
[146] Jeffrey L Duerk,et al. Determining and optimizing the precision of quantitative measurements of perfusion from dynamic contrast enhanced MRI , 2003, Journal of magnetic resonance imaging : JMRI.
[147] P. Fransson,et al. The pelvis after surgery and radio-chemotherapy for rectal cancer studied with Gd-DTPA-enhanced fast dynamic MR imaging , 1998, European Radiology.
[148] D Artemov,et al. Tumor angiogenesis, vascularization, and contrast-enhanced magnetic resonance imaging. , 1999, Topics in magnetic resonance imaging : TMRI.
[149] A P Pathak,et al. MR‐derived cerebral blood volume maps: Issues regarding histological validation and assessment of tumor angiogenesis , 2001, Magnetic resonance in medicine.
[150] Evaluation of tumor proliferation using dynamic contrast enhanced-MRI of oral cavity and oropharyngeal squamous cell carcinoma. , 2003, Oral oncology.
[151] G Brix,et al. Multicompartment analysis of gadolinium chelate kinetics: Blood‐tissue exchange in mammary tumors as monitored by dynamic MR imaging , 1999, Journal of magnetic resonance imaging : JMRI.
[152] T Kubota,et al. Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging. , 1993, Radiology.
[153] Invasive Carcinomas and Fibroadenomas of the Breast: Comparison of Microvessel Distributions-Implications for Imaging Modalities , 1998 .
[154] N Karssemeijer,et al. Staging urinary bladder cancer after transurethral biopsy: value of fast dynamic contrast-enhanced MR imaging. , 1996, Radiology.
[155] P. Vaupel,et al. The Role of the Microcirculation in the Treatment of Malignant Tumors: Facts and Fiction , 2000 .
[156] David L Buckley,et al. Uncertainty in the analysis of tracer kinetics using dynamic contrast‐enhanced T1‐weighted MRI , 2002, Magnetic resonance in medicine.
[157] R. Gilles,et al. Ductal carcinoma in situ: MR imaging-histopathologic correlation. , 1995, Radiology.
[158] B R Rosen,et al. Hyperacute stroke: simultaneous measurement of relative cerebral blood volume, relative cerebral blood flow, and mean tissue transit time. , 1999, Radiology.
[159] B K Rutt,et al. Temporal sampling requirements for the tracer kinetics modeling of breast disease. , 1998, Magnetic resonance imaging.
[160] W. Rooney,et al. Determination of the MRI contrast agent concentration time course in vivo following bolus injection: Effect of equilibrium transcytolemmal water exchange , 2000, Magnetic resonance in medicine.
[161] Jamal Zweit,et al. Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implications for trial design of antiangiogenic antibodies. , 2002, Journal of the National Cancer Institute.
[162] P.-F. Liu,et al. MRI of the uterus, uterine cervix, and vagina: diagnostic performance of dynamic contrast-enhanced fast multiplanar gradient-echo imaging in comparison with fast spin-echo T2-weighted pulse imaging , 1998, European Radiology.
[163] J C Waterton,et al. Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined T1 and T2* contrast‐enhanced dynamic MR imaging , 2000, Journal of magnetic resonance imaging : JMRI.